Literature DB >> 8724654

Hypoxic-ischemic injury acutely disrupts microtubule-associated protein 2 immunostaining in neonatal rat brain.

C Malinak1, F S Silverstein.   

Abstract

We evaluated the influence of an acute hypoxic-ischemic insult on the neuronal dendritic cytoskeletal protein microtubule-associated protein 2 (MAP2) in the immature rat brain. Studies were performed using a well-characterized perinatal rodent stroke model, in which unilateral ischemic forebrain injury was induced in 7-day-old rats by right carotid artery ligation, followed by 3 h exposure to 8% oxygen. Changes in the neuroanatomic distribution of MAP2 in the first 48 h after injury were evaluated by immunocytochemistry with a monoclonal mouse anti-MAP2 antibody. The distribution of MAP2 immunoreactivity was markedly disrupted in the lesioned hippocampus; prominent reductions in MAP2 immunostaining evolved concurrently in lesioned cortex, caudate and thalamus. These data demonstrate that at this developmental stage, MAP2 immunocytochemistry provides a sensitive indicator of the distribution and severity of hypoxic-ischemic neuronal injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724654     DOI: 10.1159/000244319

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  15 in total

1.  Disrupted synaptic development in the hypoxic newborn brain.

Authors:  Sheila M Curristin; Anjun Cao; William B Stewart; Heping Zhang; Joseph A Madri; Jon S Morrow; Laura R Ment
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

2.  The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neurons.

Authors:  Sarah E Andiman; Robin L Haynes; Felicia L Trachtenberg; Saraid S Billiards; Rebecca D Folkerth; Joseph J Volpe; Hannah C Kinney
Journal:  Brain Pathol       Date:  2010-02-08       Impact factor: 6.508

3.  Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep.

Authors:  M Schwab; I Antonow-Schlorke; B Kühn; T Müller; H Schubert; B Walter; U Sliwka; P W Nathanielsz
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

4.  HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors.

Authors:  Yoon-La Choi; Chong Jai Kim; Tatsuya Matsuo; Carlo Gaetano; Rita Falconi; Yeon-Lim Suh; Seok-Hyung Kim; Young Kee Shin; Seong Hoe Park; Je Geun Chi; Carol J Thiele
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

5.  Ischemic tolerance in an in vivo model of glutamate preconditioning.

Authors:  Yomna Badawi; Ranu Pal; Dongwei Hui; Elias K Michaelis; Honglian Shi
Journal:  J Neurosci Res       Date:  2014-11-25       Impact factor: 4.164

6.  Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Cheryl Stevens; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2011-01       Impact factor: 4.994

7.  Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow.

Authors:  M Schwab; M Roedel; M A Anwar; T Müller; H Schubert; L F Buchwalder; B Walter; W Nathalielsz
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

8.  Quantitative analysis of MAP2 immunoreactivity in human neocortex of three patients surviving after brain ischemia.

Authors:  Victor A Akulinin; Annica Dahlstrom
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

9.  Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain.

Authors:  Iwa Antonow-Schlorke; Matthias Schwab; Cun Li; Peter W Nathanielsz
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

Review 10.  Clinical neuropathology practice guide 5-2013: markers of neuronal maturation.

Authors:  Harvey B Sarnat
Journal:  Clin Neuropathol       Date:  2013 Sep-Oct       Impact factor: 1.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.